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Background: Somatosensory stimulation of the lower extremity could improve motor
recovery and walking post-stroke. This pilot study investigated the feasibility of a
subsequent randomized controlled trial (RCT) to determine whether task-specific
gait training is more effective following either (a) intensive hands-on somatosensory
stimulation or (b) wearing textured insoles.
Objectives: Determine recruitment and attrition rates, adherence to intervention,
acceptability and viability of interventions and outcome measures, and estimate variance
of outcome data to inform sample size for a subsequent RCT.
Methods: Design: randomized, single-blinded, mixed-methods pilot study.
Setting: In-patient rehabilitation ward and community.
Participants: n = 34, 18+years, 42–112 days following anterior or posterior circulation
stroke, able to follow simple commands, able to walk independently pre-stroke, and
providing informed consent.
Intervention: Twenty 30-min sessions of task-specific gait training (TSGT) (delivered
over 6 weeks) in addition to either: (a) 30–60min mobilization and tactile stimulation
(MTS); or (b) unlimited textured insole (TI) wearing.
Outcomes: Ankle range of movement (electrogoniometer), touch-pressure sensory
thresholds (Semmes Weinstein Monofilaments), motor impairment (Lower Extremity
Motricity Index), walking ability and speed (Functional Ambulation Category, 5-m walk
test, pressure insoles) and function (modified Rivermead Mobility Index), measured
before randomization, post-intervention, and 1-month thereafter (follow-up). Adherence
to allocated intervention and actual dose delivered (fidelity) were documented in case
report forms and daily diaries. Focus groups further explored acceptability of interventions
and study experience.
Analysis: Recruitment, attrition, and dose adherence rates were calculated as
percentages of possible totals. Thematic analysis of daily diaries and focus group data
was undertaken. Standard deviations of outcome measures were calculated and used
to inform a sample size calculation.
Aries et al. MoTaStim-Foot: A Pilot Study
Results: Recruitment, attrition, and adherence rates were 48.57, 5.88, and 96.88%,
respectively. Focus groups, daily-diaries and case report forms indicated acceptability
of interventions and outcome measures to participants. The 5-m walk was selected as
primary outcomemeasure for a future trial [mean (SD) at end of intervention: 16.86 (11.24)
MTS group and 21.56 (13.57) TI group]; sample size calculation indicated 60 participants
are required per group.
Conclusion: Recruitment, attrition and adherence rates and acceptability of
interventions and outcomes justify a subsequent powered RCT of MTS+TSGT compared
with TI+TSGT.
Keywords: stroke, rehabilitation, somatosensory stimulation, lower extremity, motor recovery, feasibility study,
sensory retraining
INTRODUCTION
Every 2 s, someone in the world experiences a stroke; there are
more than 1.2 million stroke survivors in the United Kingdom
(UK) alone (1). Many stroke survivors—between 65% (2) and
85% (3)—experience somatosensory impairment. This impacts
adversely on the ability to detect, discriminate, and recognise
sensations from the body because somatosensory function
includes tactile sensation, vibration, pressure, proprioception,
temperature, and pain (4). Somatosensory impairment of the
lower limb is experienced by between 45% (5) and 56% (6)
of stroke survivors and makes performance of everyday tasks
difficult (5, 7). Consequently, potential for achieving independent
walking post-stroke is decreased (8).
Regaining the ability to walk is a priority for many stroke
survivors. Identifying best treatments to address balance, gait,
and mobility has been identified by the James Lind Alliance as
one of the top 10 research priorities for stroke (9). Progress is
promised by interventions aiming to reduce motor impairment
and thus recovery of body functions toward their pre-stroke
state by utilising the principles of activity-driven neuroplasticity
(10). Interventions to facilitate activity-driven neuroplasticity
are placed into a framework of priming, augmentation, and
practise (11).
Priming interventions prepare the sensorimotor system for
motor function, specifically when limited or no volitional
control of movement exists. Priming can be achieved through
the provision of somatosensory stimulation as a precursor
to task-specific training (11). Therapists can deliver intensive
proprioceptive and tactile stimulation through a hands-on
intervention known as mobilization and tactile stimulation
(MTS) (12). Research into MTS for the contralesional hand
post-stroke found reduction of motor impairment and improved
Abbreviations: 5MWT, Five metre walk test; LEMI, Lower Extremity Motricity
Index; MoTaStim-Foot, Mobilization and Tactile Stimulation of the Foot; mRMI,
Modified Rivermead Mobility Index; MTS, Mobilization and tactile stimulation;
NIHSS, National Institutes of Health Stroke Scale; PPIE, Patient and public
involvement and engagement; SWMs, Semmes Weinstein monofilaments; TI,
Textured insole; TSGT, Task-specific gait training. CI, Confidence interval; IQR,
Interquartile range; NHS, National Health Service; SD, Standard deviation; UK,
United Kingdom.
upper-limb function (13, 14). MTS is also applied to the foot
(15, 16). It is hypothesised that greater somatosensory awareness
and alignment of the foot, through intensive somatosensory
stimulation using MTS, improves the ability to place and transfer
weight over the foot, permitting adaptation to different floor
surfaces. However, this has not yet been tested.
Augmenting interventionsmay also enhance somatosensation
during task-specific activity. For example, standing on textured
materials (17) and wearing textured insoles (TIs) in shoes to
improve perceptual motor performance (18). TIs are designed
to stimulate sensory receptors on the plantar surface of the
foot: tactile (19), pressure (20), and vibration (21). Afferent
information from the foot and ankle is, therefore, crucial for
postural control and walking capacity (22). TIs that enhance
sensory awareness of the foot during motor activity are also
expected to improve contact of the foot with the supporting
surface and thus interaction between the foot and the floor, which
is important for functional activity (23). The use of TIs is a
“hands-off,” low-cost augmentation strategy that has been shown
to reduce mediolateral sway in healthy populations (24), and
change spatiotemporal gait parameters in people with multiple
sclerosis (25). However, TIs have not yet been investigated in a
stroke population, stimulating the contralesional side.
Practice interventions use task-specific training, which is
recommended when stroke survivors can repeat and practice
movements or tasks (11). Task-specific training has been
shown to improve motor function post-stroke (26–28). More
specifically, task-specific gait training (TSGT) is an effective
intervention after stroke (26, 29–31).
It is known that afferent input can influence motor control
(32, 33). However, it is not known whether combining
TSGT with somatosensory stimulation—either priming using
MTS, or augmentation by wearing TIs—would increase the
effect. The hypothesis is that MTS (priming intervention)
immediately before TSGT has greater efficacy than TSGT
combined with wearing TIs (augmentation intervention) in
reducing sensorimotor impairment and improving functional
ability of the more paretic lower limb after stroke. Before this
hypothesis can be tested in an adequately powered randomized
controlled trial (RCT) it was important to undertake a pilot study
to determine the viability of a subsequent RCT (34, 35).
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The objectives for this study were to:
1. Estimate recruitment rate for a subsequent RCT.
2. Estimate attrition rate for a subsequent RCT.
3. Estimate the adherence rate to the interventions and their
acceptability to participants.
4. Investigate acceptability and feasibility (effective delivery
and success of blinding) of a battery of outcome measures,
to inform primary and secondary outcome measures for a
future trial.
5. Undertake a sample size calculation for a subsequent
RCT, using the estimated variance of the selected primary
outcome measure.
6. Monitor the type and frequency of adverse events.
MATERIALS AND METHODS
Design, Randomization, Ethics, Trial
Registration, and Procedure
We undertook a two-group, randomized, single-blinded
pilot study with an embedded qualitative investigation using
participant self-report in daily diaries, and focus groups.
Randomization of participants to one of two groups
(MTS+TSGT or TIs+TSGT) was undertaken by the Norwich
Clinical Trials Unit, using a computer randomization system in
a 1:1 ratio with permuted blocks of two and four. Stratification
by left- or right-sided brain lesion (identified from the medical
notes) was used because this factor may influence rehabilitation
potential (36). Group allocation order was concealed from
the research team until after a participant had completed the
measurement battery at baseline (37).
All outcome measurements in which observer bias could
occur were undertaken by assessors blinded to treatment group
allocation. Measures were employed to enhance blinding. To
avoid a chance observation of insoles unblinding the assessor, all
participants were provided with one pair of insoles, but those in
theMTS+TSGT group were told not to use them. On completion
of the interventions all the TIs were collected and observed for
any indications that they had been worn. In addition, participants
were asked not to disclose group allocation to the blinded
assessor and the case report forms were not accessible to the
blinded assessor.
Research ethics approval for this study was obtained from
the UK National Research Ethics Service (4/3/16), IRAS No:
171968/REC Ref 16/WM/0080. All participants gave informed
consent. The study was registered on a clinical trials database
(ISRCTN 13676183; Central Portfolio Management System ID
30449). The study sponsor was Keele University.
Following eligibility screening and after providing written
informed consent, participants undertook the measurement
battery at baseline (prior to randomization), after 20 sessions
of intervention (end of intervention), and 1 month thereafter
(follow-up). Progress measures within the intervention phase
were also recorded after 5, 10, and 15 treatments, and participants
kept a daily diary during the intervention phase. Post-study focus
groups explored participant acceptability and feasibility of the
interventions and outcome measures. An overview of the study
is given in Figure 1.
Participants
We recruited adults (aged 18 years or older) with stroke occurring
in any brain area 42–112 days prior to providing informed
consent. Specific inclusion criteria were: able to follow simple
commands and imitate actions using the less paretic (ipsilesional)
upper limb; able to walk independently prior to index stroke
with or without a walking aid; and unable to step on and off
a 7·5 cm high block more than 12 times in 15 s with either the
more paretic (contralesional) or less paretic (ipsilesional) lower
limb (38). Exclusion criteria were: any pathology or previous
stroke affecting lower-limb sensation e.g., diabetic neuropathy;
fixed contracture of the tendo Achillis; pressure sores or ulcers
on the foot or contralesional ankle; any pathology affecting blood
circulation to or from the contralesional foot; botulinum toxin
injection to the contralesional lower limb in the previous 6
months; pain sufficient to prevent undertaking interventions or
outcomes; and known HIV, hepatitis non-A or related condition
(to meet sponsor requirements).
Where posterior circulation stroke had caused paresis in
either the ipsilesional side or both sides of the body, prior to
randomization we consulted the participant’s therapist, whose
opinion was accepted in relation to identifying the more
paretic side.
Sample Size, Setting, and Recruitment
A sample of 34 was considered achievable and adequate to enable
a sample size calculation for the subsequent RCT by estimating
variance on a continuous outcome measure (39, 40), accounting
for 10% attrition (objective 5).
The study was conducted in an in-patient stroke rehabilitation
ward and community-based Stroke Early Supported Discharge
service. Potential participants were identified by research nurses
or multidisciplinary stroke teams. Stroke survivors (42–112 days
post-stroke) expressing an interest in participating were given
a participant information sheet. The first 34 stroke survivors
meeting inclusion criteria and providing written informed
consent were recruited. The study interventions and outcome
measurements were performed either in an inpatient clinical
setting within an NHS organisation or at the participant’s own
home, depending upon where the participant resided at that
time. However, wherever possible the location for undertaking
the outcome measures at baseline was replicated for the end of
intervention and 1-month measures.
Interventions
Each group received one of two interventions, either
MTS+TSGT or TIs+TSGT: 20 sessions delivered within a
6-week period. If participants were receiving routine therapy
(usual care), this continued alongside the study interventions.
Dose and content of routine therapy were recorded on a
treatment record (41) by the clinical team.
Standardisation of the three components of the two
interventions was facilitated by developing protocols,
co-produced with experienced therapists, using a
Frontiers in Neurology | www.frontiersin.org 3 July 2021 | Volume 12 | Article 675106
Aries et al. MoTaStim-Foot: A Pilot Study
FIGURE 1 | Overview of the study design. FAC, Functional Ambulation Category; mRMI, modified Rivermead Mobility Index; MTS, Mobilization and tactile stimulation;
NIHSS, National Institutes of Health Stroke Scale; TI, Textured insole.
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modified nominal group technique (42), and the
Template for Intervention Description and Replication
(TIDieR) checklist (43). This was a “dynamic iterative
process, involving stakeholders, and reviewing published
research evidence, drawing on existing theories”
[(44) p. 1].
Research therapists (n = 4) received training in applying and
delivering all interventions. To assess fidelity to protocol, the
research therapists were observed by a senior member of the
project team (SMH) at various points during the study to ensure
they were working to protocol.
Mobilization and Tactile Stimulation for the
More Paretic Lower Limb
MTS+TSGT group participants received 30–60min of
standardised lower-limbMTS [based upon a dose-response study
of MTS for the upper limb (45)] (Figure 2) immediately prior to
TSGT. MTS consisted of physical therapy techniques from six
intervention categories: (1) passive and accessory movements
of joints, (2) massage and soft tissue stretch, (3) creating an
active foot in preparation for stance/balance, (4) specific sensory
input, (5) isolated/selective joint movement, and (6) patterns
of coordinated movement underlying functional activity. The
MTS schedule is a module rather than a single intervention,
with flexibility to provide individualised interventions to each
participant within the confines of themodule. Research therapists
selected and delivered appropriate combinations of techniques
to address specific clinical needs of participants, influenced by
multiple issues (46), thereby reflecting clinical reality. Selections
and combinations were based upon clinical decisions; it was
neither necessary nor appropriate to deliver all techniques in the
schedule to all participants. This allowed consideration of issues
such as foot hypersensitivity and tolerance of techniques.
Wearing a Textured Insole in the Shoe of
the Contralesional Lower Limb
For TI+TSGT group participants, one TI was placed in the shoe
worn on the contralesional foot, and one smooth insole in the
shoe worn on the ipsilesional foot. The TI was black, OG1549,
with small, pyramidal peaks, with centre-to-centre distances of
∼2.5mm Evalite Pyramid EVA, of 3-mm thickness, Shore value
A50 (Figure 3). The smooth insole consisted of medium density
EVA, 3-mm thickness, Shore value A50, black, OG1304. Both
insoles were made from material manufactured by Algeos UK
Ltd., Liverpool, UK1.
Insoles were participant-specific and cut to size to fit in
each individual shoe. The TI protocol is presented in Table 1.
In summary, participants were encouraged to wear the insoles
daily for as long as they chose, with advice to gradually increase
wearing duration during the 6-week intervention period. They
were provided with daily diary sheets to note wearing time (MTS
and TI daily diaries in Supplementary Material).
1Algeos UK Ltd (http://www.algeos.com/).
Task-Specific Gait Training
Thirty minutes of TSGT were delivered to all participants
in both groups, either immediately following MTS treatment
(MTS+TSGT group), or while participants wore the insoles
(TI+TSGT group), in accordance with the TSGT protocol
(Table 2). The specific content of each gait-training session was
documented using the comprehensive list of TSGT interventions
described (TSGT record in Supplementary Material).
Data Collection
Originally, we intended to undertake blood flow studies using a
portable ultrasound machine to explore whether changes occur
in response to MTS treatment. However, this proved not to be
feasible due to sonographer time constraints.
Participant Characteristics at Baseline
Data recorded at baseline were: participant demographics;
clinical characteristics, including theNational Institutes of Health
Stroke Scale (NIHSS) (51)2; self-report of walking distance; and
the Functional Ambulation Category (52).
Intervention Fidelity and Adherence to
Protocol
Delivery ofMTSwas recorded according to length of each session
(minutes). The number of sessions delivered was also recorded.
Adherence to protocol was accepted if participants received at
least 30min of MTS (and <60min) in each intervention session.
Understanding optimal treatment dose, as advocated by the
second Stroke Recovery and Rehabilitation Roundtable (53), is
important to inform future trials.
Participants recorded duration of wearing insoles each day in
their daily diary, and it was also reported in case report forms.
Delivery of TSGT was recorded according to length of each
session (minutes) and adherence calculated as the number of
sessions within 10% of the 30min specified in the protocol.
Lower-Limb Sensorimotor Impairment and
Functional Ability
Table 3 provides full details of measures of lower-limb
sensorimotor impairment and functional ability and time
points for their administration.
To meet objective 4 and enable selection of a primary
outcome measure and sample size calculation (objective 5),
a battery of outcome measures was chosen. In relation
to the International Classification of Functioning, Disability
and Health (ICF) (64), the interventions delivered aimed to
alter body structures and functions and activity; participation
was also explored through the focus groups. We considered
previously reported appropriateness of each outcome measure
for measuring sensorimotor impairment or lower-limb function
and balance, as well as attention to validity, reliability and
responsiveness to change (65, 66).
2http://www.nihstrokescale.org/
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FIGURE 2 | Treatment schedule for mobilization and tactile stimulation to the lower limb.
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FIGURE 3 | Smooth and textured insole (TI), with a close-up of the pyramidal peaks of the textured material.
Sensorimotor Impairment
Clinically relevant measures of sensorimotor impairment were
selected to explore sensory or motor changes based upon
potential mechanisms of effect, to enable effectiveness to be
explored in a future study. Wherever possible, procedures were
standardised, and staff were trained appropriately.
In view of the potential for TIs to augment somatosensation
and facilitate sensorimotor control whilst being worn, we
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TABLE 1 | Protocol for the textured insole group (based on the Template for Intervention Description and Replication, TIDieR checklist).
1 Name: Textured insole (TI) protocol for TI group
2 Rationale: The plantar (sole of the foot) mechanoreceptors are key, sending information to the CNS; plantar stimulation
has been shown to result in increased control of body sway (47). In view of the importance of cutaneous
information from the plantar surface of the foot to control balance (48), other potential mechanisms of
increasing plantar stimulation have been explored. TIs improve postural control in standing in healthy
participants (49), walking patterns for people with multiple sclerosis (25). However, the combination of
wearing TIs and task-specific gait training (TSGT) has not been evaluated to determine the benefits for
balance and walking recovery early after stroke. The use of TIs in the shoes of stroke survivors involves a
hands-off (therapist independent) approach, which may potentially be a more economical option for achieving
increased sensory stimulation to the foot and is, therefore, important to investigate.
3 Materials: Smooth and TIs will be patient specific and cut to size so they fit in the participant’s shoe. Both insoles are
manufactured by Algeos UK Ltd., Liverpool, UK. The smooth surface will be of medium density EVA, 3mm
thickness, Shore value A50, black, OG1304. The TI has small, pyramidal peaks with centre-to-centre
distances of ∼2.5mm Evalite Pyramid EVA, 3mm thickness, Shore value A50, black, OG1549.
4 Procedures: This group of participants will be encouraged to wear the TI on the contralesional side (and a smooth insole
the opposite side), as much as possible (to “augment” the sensorimotor system), during the 4–6-week
intervention period, except when the outcomes are being assessed. In addition to wearing the TIs
participants will also receive 20 sessions of TSGT (30min each session), during the intervention period. The
specific content of each treatment session will be documented; daily diaries will inform the research team of
the extent of wearing of the TIs. Outcome measures will be undertaken without the participant wearing TIs, so
it is the same conditions as the mobilization and tactile stimulation group, which is the other arm of the trial.
5 Provided by: Participant is responsible for wearing textured/smooth insoles. If help is needed to put TIs into shoes and put
on footwear (and no family support is available), a Research Therapist will assist, prior to TSGT.
6 Mode of delivery: Participant controlled—wearing the TIs for as much as possible during the 4–6-week intervention period. The
Research Therapist will help if required to put the TIs into shoes and put on footwear prior to TSGT if
required. The participant will, therefore, wear the TIs a minimum of 30min 4–5 times per week.
7 Location: The participants will be encouraged to wear the TIs and receive the TSGT in their own environment, whether
this is as an inpatient or their own home.
8 When and how much: Time wearing the insoles will vary. Some participants may just wear them during the TSGT and others may
wear them for long periods in the day. Participants will be encouraged to record the length of time insoles are
worn on the daily diaries.
9 Tailoring: The participant is in control of time wearing insoles, tailoring intervention to their comfort and needs.
10 Modifications: Any modifications to the TI protocol will be recorded.
11 Intervention adherence and fidelity: Planning: Intervention adherence and fidelity will be assessed. Strategies to improve fidelity and adherence
include: research therapist training, encouragement and motivation regarding wearing of TIs by the research
therapist delivering the TSGT and the keeping of daily diaries which will be collected weekly. A record of the
length of time wearing the insoles will be included as a prompt in the simple diaries and this information will
enable monitoring of adherence and fidelity. The information from the daily diaries will be analysed by the
Chief Investigator, with additional guidance from the research team.
12 Intervention adherence and fidelity: How well, actual: The analysis of the daily diary sheets will give an indication of adherence to the
intervention. The focus groups will enable further opportunity of assessing the adherence, fidelity and
acceptability of the intervention.
TI, Textured insole; TSGT, Task-specific gait training.
removed these from footwear before undertaking outcome
measure assessment to ensure parity of testing conditions for
both groups.
The Lower Extremity Motricity Index (LEMI), a valid and
reliable (56, 57) measure with no cost implications—with scores
ranging from 0 (no movement) to 33 (full strength) for each of
three joints tested in a limb, i.e., hip, knee and ankle; a final one
point is added so it can be scored out of 100 (57)—was used
according to a standardised protocol developed for the trial to
monitor strength of hip and knee flexors and ankle dorsiflexors.
We measured ankle range of movement during gait and
analysed ankle dorsiflexion and inversion during stance phase,
using an electrogoniometer3, costing £4,611, attached to the
3http://www.biometricsltd.com/gonio.htm
lateral border of the lower leg. The sensor was positioned
vertically in alignment with the lateral malleolus; the data log
acquisition unit was calibrated (zeroed) with the participant
standing in a neutral position (67). Maximum range of ankle
dorsiflexion and inversion movement was recorded during the
5-metre walk test (5MWT); range of knee motion was not
measured. Data were extracted from the Biometrics programme
and run through a Matlab programme to provide results in
degrees of movement. The participants were videoed during the
5MWT to give a visual representation of gait for interest; the
video was available for participants to view if they wished to.
Touch/pressure sensory thresholds in the feet relate to
activity outcomes (68) and Semmes Weinstein monofilaments
(SWMs), costing £240, were therefore selected as an outcome
measure for this study. SWMs are a reproducible method
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TABLE 2 | TSGT protocol based on the Template for Intervention Description and Replication (TIDieR) checklist.
1 Name: Task-specific gait training (TSGT) group.
2 Rationale: Walking is a priority for many stroke survivors, confirmed by studies undertaken to define a national
research agenda, which identified physical therapy to address balance and gait (walking)
post-stroke within the top 10 research priorities [James Lind Alliance, (9)]. There is strong evidence
that task-specific walking practice can be used to improve walking after stroke (50).
3 Materials: Based upon a review of the literature and a focus group with experienced clinicians a few pieces of
equipment will be required including theraband, football, chair, foam cushion, gym ball a stair or
step and a wobble board.
4 Procedures: 30min of TSGT will be supervised by the research therapist, with 20 sessions being delivered over a
4–6-week intervention period. The TSGT will be undertaken immediately after the mobilization and
tactile stimulation (MTS) for the MTS group. The TSGT will be undertaken whilst wearing a TI on the
contralesional side and a smooth insole on the other side, for the TI group
5 Provided by: The TSGT will be delivered by a research therapist (Band 6), with experience of working with stroke
patients. A log will be kept of which research therapist provides which treatment for each participant
and this information will be analysed on completion of the trial.
6 Mode of delivery: The research therapist will provide the TSGT in a 1:1 situation.
7 Location: The TSGT will take place in either an inpatient clinical setting within an NHS organisation or a
University research setting or the participant’s own home.
8 When and how much: All participants in both groups/arms of the trial will receive 20 sessions of 30min of TSGT within a
4–6-week period.
9 Tailoring: Although a standardised protocol will be followed for the TSGT the research therapist will choose
appropriate exercises and adapt them as required to suit the requirements of each individual
participant, due to differences in presentation following a stroke. This reflects how TSGT would
usually be implemented in conventional rehabilitation. Details of actual intervention delivered will be
recorded on the treatment schedule.
10 Modifications: Any modifications to the TSGT protocol will be monitored and reported appropriately.
11 Intervention adherence and fidelity- planned: Intervention adherence and fidelity will be analysed. Strategies to improve fidelity and adherence
include 1:1 intervention plus encouragement and motivation strategies by the research therapist
during the TSGT, as in usual therapy rehabilitation. A log will be kept detailing, for each participant,
which research therapist has delivered the TSGT.
12 Intervention adherence and fidelity—how well (actual): The case report files completed by the research therapists will give an indication of adherence to the
intervention. The focus groups will enable further opportunity of assessing the adherence, fidelity,
and acceptability of the intervention.
MTS, Mobilization and tactile stimulation; TSGT, Task-specific gait training.
of assessing somatosensation (55). Touch/pressure sensory
threshold was established by identifying the minimum force
required to accurately identify touch/pressure threshold and was
measured using SWMs at four anatomical points located on
the plantar surface of the foot: mid-heel; pad of the hallux;
1st metatarsophalangeal (MTP) joint; and 5th MTP joint (56).
We developed a bespoke protocol informed by the literature to
reduce potential testing fatigue and this was used successfully
following training of assessors (Supplementary Material).
Pressure under the feet was measured during stance phase
of walking using the TEKSCANTM (F-ScanTM) system, costing
∼£14,000, which involved inserting thin insoles (containing 960
separate pressure-sensing cells arranged in rows and columns)
into participants’ shoes. Following calibration, force-time integral
and centre of force velocity (COFV) were measured (59).
Symmetry of gait was not a focus of this pilot study.
Functional Ability
We selected clinically relevant measures of lower-limb functional
ability to explore changes in function, specifically balance and
walking, which had potential to enable effectiveness to be
explored in a future study.
The Functional Ambulation Category (FAC), which had no
cost implications, measured walking ability (scored from 0,
non-functional ambulator to 5, ambulator, independent) (52);
the research assessor selected the appropriate category after
observing the participant walk. The 5MWT, which also had no
cost implications, measured walking speed (58). However, the
environment for undertaking assessment and standardisation of
the measure should be considered. Suzuki et al. (69) advocated a
3-metre (m) lead-up (thus a total of 8m), and Salbach et al. (58)
advised 2m to allow acceleration, and a further 2m at the end
for deceleration (thus a total of 9m). This straight distance is not
usually available in participants’ homes; a modified 5MWT was,
therefore, conducted.
Functional mobility (bed mobility, transfers, sitting and
standing balance, walking and stairs) was assessed using the
modified Rivermead Mobility Index (mRMI), which again had
no cost implications (61). A maximum score of 40 is possible
for the mRMI. Owing to lack of access for stair assessments
in some homes, to maintain parity across participants, we
omitted the stairs section when calculating the mRMI (maximum
score 35). The full validated mRMI measure was, therefore,
not used.
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TABLE 3 | Summary of outcomes for the MoTaStim-Foot pilot study.














Provides ratio-level data (cm)
Intra-rater reliability r = 0.979 (54).
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threshold of plantar
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joint and 5th MTP joint
Semmes Weinstein
monofilaments (SWMs),








Provides ordinal data; filaments are numbered
1–20. One represents the largest force (300 g,
6.65) and 20 the smallest force (0.008 g, 1.65).
Intra-rater reliability has been reported to be an
r value of >0.9 when a specific protocol was
followed (55).
Motor impairment (strength)










Provides interval level data. For individual
actions (ankle dorsiflexion, knee extension and
hip flexion) and all actions combined, Pearson
correlations—good to excellent (r =
0.78–0.91), significant (p < 0.001) (56).
Excellent test-retest intra-rater reliability of the
Lower Extremity Motricity Index (LEMI) as a









Provides categorical/nominal data. Valid and
responsive, with excellent intra-rater reliability
(Cohen k = 0.950) and inter-rater reliability (k =
0.905) in stroke survivors (52).





Provides ratio-level data (seconds). 5MWT was
shown to have a standardised response mean
(95%CI) of 1.22 (0.93, 1.50) at a comfortable
pace and 1.00 (0.68, 1.30) at a maximum
walking pace (58)
Pressure under the feet
during stance phase of
walking
TEKSCANTM (F-ScanTM)
pressure insoles to record
force-time integral (FTI) and
centre of force velocity




Provides ratio-level data force time integral (FTI)
(N/sec) and (COFV) (cm/sec). Foot Scan
pressure insole systems have been found
generally to provide reliable force and pressure
data (ICC > 0.75) (59). Pressure insoles (the
Parotec System) have shown a very strong
degree of association with an Advanced
Mechanical Technology Inc. (AMTI) force plate
when measuring COP in an AP direction with
Pearson’s correlation coefficients—greater than
0.90 for 67/67 trials (100%) (60).





Provides ordinal level data. Inter-rater reliability
excellent = 0.98 (p<0.001) (61). The minimal
clinically relevant difference is 4.5 points.
Participants’ perceptions of
the acceptability of the
interventions and outcome
measures




period. Attendance at a
focus group on completion
of all the interventions and
measures
Focus groups were used to provide an insight
into the participants’ trial experiences (62).
Topic guides were used. A patient and public
involvement and engagement (PPIE) advisor
assisted with note-taking and summarising the
information discussed at the end of each focus
group. Braun and Clarke’s (63) six-stage
process for thematic analysis was broadly
followed.
5MWT, Five metre walk test; AP, Anterior-posterior; Cm, Centimetres; COFV, Centre of force velocity; COP, Centre of pressure; FAC, Functional Ambulation Category; FTI, Force time
integral; ICC, Intraclass correlation co-efficient; LEMI, Lower Extremity Motricity Index; N/sec, Newtons per second; SWMs, Semmes Weinstein monofilaments.
Observer Blinding
At 1-month follow-up, the blinded assessor was asked to
indicate to which group she thought the participant had been
allocated (reported as a percentage of correctly guessed group
allocations); this allowed us to assess the success of observer-
blinding procedures.
Daily Diaries
Throughout the intervention period, participants were asked
to keep a daily diary to help them to “focus their thoughts”
[(70), p. 993] and record any changing perception of their
lower limb (sensation, movement, or function), and their
experiences of interventions and outcomes. These qualitative
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TABLE 4 | Participant characteristics and demographics at baseline.
MTS (n = 19) Textured Insole (n = 15) All (n = 34)
Age (years) Mean (SD) 73.8 (14.1) 72.4 (9.8) 73.2 (12.2)
Sex Male; n (%) 9 (47.4) 9 (60.0) 18 (52.9)
Female; n (%) 10 (52.6) 6 (40.0) 16 (47.1)
Type of stroke Ischemic; n (%) 17 (89.5) 12 (80.0) 29 (85.3)
Haemorrhagic; n (%) 2 (10.5) 3 (20.0) 5 (14.7)
Side of brain lesion Left (%) 11 (57.9) 9 (60.0) 20 (58.8)
Right (%) 8 (42.1) 6 (40.0) 14 (41.2)
Days after stroke Mean (SD) 59.5 (18.1) 53.9 (12.4) 57.0
Range 43–106 43–95 43–106
Walking prior to stroke % able to walk >1mile prior to stroke 68.4 73.3 70.6
NIHSS Median (IQR) 6.00 (4.00, 7.25) 5.00 (4.00, 7.00) 5.00 (4.00, 7.00)
Range 1–11 3–16 1–16
FAC Median (IQR) 4 (2, 5) 3 (1, 4) 3 (2, 4.25)
Range 1–4 1–4 1–4
FAC, Functional Ambulation Category; MTS, Mobilization and tactile stimulation; NIHSS, National Institutes of Health Stroke Scale; TI, Textured insole.
data aimed to gain an understanding of acceptability of
the interventions and outcome measures (objectives 3
and 4).
Focus Groups
After follow-up data had been collected, all participants were
invited to attend one of two focus groups, according to group
allocation (two focus groups for each intervention group),
exploring their study experiences (62) and the acceptability
of the intervention and outcome measures (objectives 3 and
4). A focus group topic guide, developed by the research
team and patient and public involvement and engagement
(PPIE) advisors, included topics relating to: participation in
the study; acceptability of interventions and outcome measures;
and perceived changes in lower-limb functions of standing,
balancing, and walking following intervention. The topic guide
was influenced by an understanding of changes that may occur
when somatosensory stimulation is delivered. Open questions
facilitated greater understanding of participants’ experiences,
enabling them to take a lead in sharing information (71). Separate
topic guides were developed for each group.
MTS+TSGT group (Supplementary Material);
TI+TSGT group (Supplementary Material).
Following consent, focus groups were audio-taped, and
moderated by one researcher (AMA). A PPIE advisor, trained to
undertake the role, took field notes. At the end of the discussion,
the moderator summarised the key issues, with assistance from
the PPIE advisor, and sought validation from participants (62).
Debrief meetings with PPIE volunteers and members of the
research team immediately after each focus group enabled
discussion of the main topic areas, identification of preliminary
themes, and topics (71) that needed further exploration in
the second focus group for that group. Debriefing also
involved evaluation of the moderator’s role and consideration of
researcher reflexivity (71). Consideration and bracketing of the
lead researcher’s assumptions (from extensive clinical experience
prior to undertaking the focus groups) continued throughout
data collection and analysis phases (72). Debriefing meetings
offered the opportunity for psychological support for PPIE
volunteers in case of unpredictable emotional response (73) to
issues raised during the focus group.
Adverse Events and Reactions
Adverse reactions of pain and fatigue were monitored, informing
about acceptability and appropriateness of interventions for
stroke survivors in future studies (objective 6). Overly intensive
TSGT has potential to elicit pain or fatigue in the contralesional
lower limb post-stroke. Therefore, pain and fatigue were
monitored and documented on the case report forms throughout
the study, using verbal report for pain and decrease in LEMI score
for fatigue.
Analysis
As this was a pilot study, no between-group analysis or formal
hypothesis testing were undertaken (74, 75).
Objectives 1 and 2
We calculated recruitment and attrition rates from the number
of patients invited to participate, the number and proportion of
those consenting to participate, the number and proportion of
eligible participants recruited, and the number and proportion of
those lost to follow-up at 1-month, which was the longest feasible
follow-up time for the study.
Objective 3
We assessed adherence to intervention protocols (MTS, wearing
TIs, and TSGT). The mean amount of TSGT delivered per group
was calculated, as well as mean duration of MTS and time
wearing TIs. Adherence was confirmed if the interventions had
been delivered to protocol.
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Objective 4
Participant acceptability, including comfort and ease of use,
of each outcome measure was assessed using data from daily
diaries and focus groups. We assessed effective delivery and
appropriateness of primary and secondary outcome measures
in terms of feasibility of administering, ability to standardise
procedures, clinical relevance, cost, psychometric properties
and level of measurement, presence of floor/ceiling effects,
responsiveness to change, as well as the number and proportion
of participants completing the outcomemeasures and variance of
scores of the measures (65).
Feasibility and acceptability of delivering interventions and
outcome measures were informed by calculating frequency of
pain, fatigue, and adverse events, and from participant feedback
(daily diaries and focus groups). The target was that outcome
measures would be completed for all participants at all three
time points and be acceptable to the participants. The results
from both quantitative and qualitative data were analysed and
synthesised to inform final decisions.
We undertook content analysis (76) of daily diary data and
thematic analysis for both focus group and daily diary data, using
Braun and Clarke’s (63) six-stage process, to explore acceptability
of interventions (MTS, TIs, and TSGT) and outcome measures
(objectives 3 and 4). Once initial coding had taken place,
data management was facilitated using NVivo qualitative data
analysis (Software QSR International Pty Ltd. Version 11, 2016).
Organisation and familiarisation of data and codes was also
enhanced by using the one-sheet-of-paper method (77).
One researcher (AMA) coded the transcribed data and
subsequently discussed codes, themes and sub-themes with two
other members of the research team (SMH and SR), who had
also coded transcripts independently, identifying provisional
themes for discussion. These provisional themes were shared
and discussed amongst the research team and an independent
PPIE representative (who had read all focus group transcripts),
enabling maturation of themes. Any differences of opinions were
discussed. The research team collectively looked for conceptual
relationships within and across the focus groups. Final themes
were identified from both the daily diaries and focus groups. We
kept an audit trail of how themes were developed and matured.
The number and proportion of participants completing all
outcome measures were calculated; floor and ceiling effects were
also explored from the data.
Objective 5
Variance of outcome measure scores was calculated, providing
information for a sample size calculation for a future main trial.
Objective 6
Adverse events and reactions were recorded.
Summarising the Results of the Study
A traffic light system (78, 79) indicating what aspects of the study
should be taken forward and any that need modification was
developed. Aspects that should not be retained were graded red,
those that could be retained but with some changes, amber and
those that could be retained without any changes green.
Study and Data Management
A Study Management Group monitored the study for adherence
to protocol and timelines. Quality assurance was supported by
the Norwich Clinical Trials Unit. We collected and stored all




A total of 34 participants were recruited to the trial. Participant
characteristics are presented in Table 4. No differences were
discernible between the MTS+TSGT and TI+TSGT groups
at baseline.
Recruitment Rate, Flow Through Study,
and Attrition Rate (Objectives 1 and 2)
Over the 18-month recruitment period, we assessed 70 stroke
survivors for eligibility. Of these, 34 (48.57%, 95% CI 37.2%,
60.0%) were recruited into the study and randomized to one of
the two interventions: 19 participants to receiveMTS+TSGT and
15 to receive TI+TSGT (Figure 4).
Attrition rate was 5.88% (95% CI 1.6%, 19.1%) at both
outcome and follow-up timepoints. Two participants were
withdrawn from the TI+TSGT group: one received a botulinum
toxin injection to the contralesional lower limb prior to
completing the first treatment session, and another developed
a lesion (unrelated to the trial) on the ipsilesional foot.
Consequently, 32 participants completed outcome and follow-
up measures.
Interventions Adherence Rates and
Acceptability (Objective 3)
All participants, apart from two withdrawn from the TI+TSGT
group, received all 20 sessions. All research therapists were
observed to be delivering the interventions to protocol.
The dose of each intervention and usual care delivered,
including actual dose achieved and adherence rate for
interventions, and the amount of routine therapy (usual
care) delivered can be seen in Table 5. The mean (SD) number of
minutes of routine therapy delivered per participant was similar
for both groups [MTS+TSGT group, 44.44 (12.48); TI+TSGT
group, 43.28 (14.61)].
Adherence and Fidelity
Prescribed dose, actual dose delivered (fidelity), and adherence
rates to protocol for delivery of MTS, TI, and TSGT are explicit
in Table 5. Adherence rate for all the interventions was good,
ranging from 94.74% (MTS) to 100% (TIs).
The lowest value of time for wearing the TIs was 0.5 h; this
occurred because one participant was unable to “don and doff”
the TIs independently, and required assistance from the research
therapist prior to TSGT.
Topic areas and themes identified from the daily diaries are
summarised in Table 6, and the content analysis in Table 7. Data
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FIGURE 4 | CONSORT diagram for the MoTaStim-Foot feasibility study.
extracted from daily diaries indicated participant acceptability
of interventions.
Four focus groups were held, two for the MTS+TSGT
group (focus group 1 n = 5; focus group 3 n = 8)
and two for the TI+TSGT group (focus group 2 n
= 5; focus group 4 n = 2). Of the 32 participants
completing the study, 20 (62.50%) attended one of the
focus groups: 13 of 19 participants (68.42%) in the
MTS+TSGT group, and 7 of 13 participants (53.85%) in
the TI+TSGT group.
We specified three main themes a priori: (1) acceptability of
interventions; (2) acceptability of outcome measures; and (3)
overall study experience (see Table 8). We derived sub-themes
from the data.
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TABLE 5 | Dose of each intervention and usual care delivered, including actual dose achieved (fidelity) and adherence rate for interventions.
MTS+TSGT TI+TSGT USUAL CARE
Number (and range) of sessions All participants (n = 19)
received 20 sessions of
both MTS and TSGT
13 participants received all
20 sessions; one participant




Mean (SD) number of sessions per participant 20.00 (0.00) 18.62 (4.99) MTS+TSGT: 9.53 (5.62)
TI+TSGT: 15.00 (11.99)





Actual dose delivered (fidelity) [mean (SD); range in minutes] MTS: 31.15 (3.47); 22–54
TSGT: 29.03 (2.58);
18.75–30.20
TIs: 462 (48); 30–720
TSGT: 30.21 (0.92);
29.25–32.65
MTS+TSGT: 44.44 (12.48) [Lower
limb focused 37.71 (21.31); upper
limb focused 19.85 (22.62)]
TI+TSGT: 43.28 (14.61) [lower limb
focused 44.86 (15.65); upper limb
focused 16.98 (22.39)]
Adherence rate* MTS: 94.74%






Measured as percentage of intervention delivered to protocol i.e., 30–60min of MTS; >30min of wearing TI.
*TSGT—within 10% of the specified 30min; N/A, not applicable.
MTS, Mobilization and tactile stimulation; SD, Standard deviation; TI, Textured insoles; TSGT, Task-specific gait training.
Theme 1: Acceptability of Interventions
Three sub-themes were identified: (dis)comfort of the
somatosensory stimulation interventions (MTS and TIs);
the challenges of TSGT; and confidence building.
Sub-theme: Comfort/Discomfort of Somatosensory
Stimulation
MTS
Content analysis of daily diaries indicated that three participants
found aspects ofMTS to be uncomfortable or painful, particularly
when the massage was deeper, using the thumb, to mobilize tight
soft tissues. However, this discomfort was generally described as
transient, lasting only a few seconds, and only experienced early
in the course of interventions. One participant reported, in the
diary, discomfort lasting for a longer period of time, and one
other participant noted discomfort that ceased after three or four
treatments. Two other participants reported no pain from MTS
at all; one participant reported it to be enjoyable.
Textured Insoles
Participants found the TIs comfortable to wear, and easy to
transfer from shoe to shoe. The textured appearance of the
insole caused an initial impression of it being potentially
uncomfortable for one participant, although discomfort was not
actually experienced when it was worn. Participants generally
liked wearing the insoles, and wore them regularly throughout
the day, some even wearing them all day. Surprisingly, some
participants preferred the sensation of the TI in the contralesional
shoe to that of the plain insole in the ipsilesional shoe.
Sub-theme: Challenges of Task Specific Gait Training
Whilst TSGT was not reported as being uncomfortable, it
was perceived to be challenging, and was described by five
participants (from three focus groups) as being hard work. It
was also perceived as being tiring, requiring rest or recovery
time afterwards, with the fatigue even manifesting itself the
following day. TSGT was considered by one participant to be
confusing, and two participants described the challenge of TSGT
as frightening.
Despite the discomfort and challenges, all three interventions
were considered acceptable by participants.
Sub-theme: Confidence Building
Interventions in this study were delivered by skilled therapists,
and their ability to demonstrate expertise and knowledge was
important to participants in terms of building confidence. The
presence of an experienced health professional appeared to
provide a level of reassurance that waned once the intervention
was withdrawn and could not be replicated by the presence of
a partner. The experienced therapist provided motivation and
instilled a sense of confidence and belief in the ability to walk.
This increased confidence and the perceived improvement in
mobility was considered by participants to be directly attributable
to the intervention, confirming its acceptability. Improvements
in balance and lower-limb control were perceived by participants
to contribute to this increased confidence and reduced fear of
falling and perceived risk of falls.
Theme 2: Acceptability of Outcome
Measures (Objective 4)
Although sometimes challenging, outcome measures were
accepted by participants as being an integral component of the
study. Overall, the selected outcome measures seemed to have a
motivating effect, perhaps making themmore acceptable, despite
the time required to complete them. Two sub-themes were
identified: usefulness of feedback, and safety.
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TABLE 6 | Topics and themes identified from the daily diaries.
MTS group TI group
Topic Themes Themes









Forgot to wear them
Awareness of insoles
Changes in feeling in foot/lower limb Temperature
Sensitivity
Able to feel foot more










General/comments related to lower limb Valued treatment
Progress





















Improved movement and balance
Sense of achievement Increased confidence
Increased strength
Independence with personal care
Ability to walk again
Ability to run again
Improved balance







Increased movement and flexibility
Improved balance





MTS, Mobilization and tactile stimulation; TI, Textured insoles; TSGT, Task-specific gait training.
Sub-theme: Usefulness of Feedback on Progress
Visual feedback from outcome measures was welcomed by
participants, who found it reassuring to see the progress made
throughout the study. Video recordings of gait during the
modified 5MWT at the start and end of the study were
particularly meaningful for one participant to illustrate the
quality of his recovering movement and function. On-screen
pixelated pressure insole data were of great interest and provided
participants with novel insights into weight distribution through
each foot in standing.
Sub-theme: Safety
The wired TekscanTM pressure insole set up was a potential safety
hazard that had to be managed carefully, particularly during the
5MWT in confined space within the home, to avoid trips over
the wires.
Theme 3: Overall Study Experience
(Objectives 3 and 4)
Participants’ experiences of the study overall were captured in
two sub-themes: intensive therapy at home and ending the study.
Sub-theme: Intensive Therapy at Home
Many participants received the interventions in their own home.
This was preferable to attending out-patient venues, as they felt
more in control and more confident in their own home. It was
easier for participants to have the therapist travelling to their
house. One participant said she would not have completed the full
course of intervention had she been required to travel to receive
it, whereas others would have been happy to travel. Regardless,
the intensity of mostly daily treatment, often delivered alongside
routine NHS therapy, was challenging for some participants.
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TABLE 7 | Content analysis of daily diaries—number of participants for each aspect ticked.
Aspects ticked in MTS group (n = 19) Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Unable to feel as much (in the foot) 1 2 2 1 0 0
Can feel more (in the foot) 15 16 13 11 14 3
MTS was uncomfortable 8 (42.11%) 7 (36.84%) 6 (31.58%) 6 (31.58%) 3 (15.79%) 4 (21.05%)
Discomfort lasted long time 0 0 0 1 1 1
Discomfort did not last long 6 6 6 6 2 4
MTS was not uncomfortable 15 (78.95%) 18 (94.74%) 17 (89.47%) 15 (78.95%) 16 (84.21%) 8 (88.89%)
TSGT was uncomfortable 3 (15.79%) 5 (26.32%) 3 (15.79%) 3 (15.79%) 2 (11.11%) 2 (13.33%)
TSGT was not uncomfortable 18 (94.74%) 17 (89.47%) 18 (94.74%) 19 (100%) 19 (100%) 9 (60%)
Outcome measurements were uncomfortable 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Outcome measurements were not uncomfortable 0 6 10 7 3 0
Aspects ticked in TI group (n = 14; n = 13 weeks 2–6) Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Unable to feel as much (in the foot) 1 1 0 0 1 0
Can feel more (in the foot) 7 6 6 6 3 4
Not worn the TIs 1 3 1 2 1 1
Worn TIs <1 h 5 3 2 1 2 1
Worn TIs 2–4 h 3 6 2 3 3 1
Worn TIs more than 5 h 8 11 11 11 12 8
Actual time worn (mean in hours) 6.01 8.05 8.02 7.86 7.72 8.55
TIs uncomfortable 1 (7.14%) 1 (7.69%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
TIs not uncomfortable 13 (92.86%) 12 (92.31%) 12 (92.31%) 12 (92.31%) 13 (100%) 9 (100%)
TSGT was uncomfortable 0 (0%) 0 (0%) 0 (0%) 1 (7.69%) 1 (7.69%) 1 (11.11%)
TSGT was not uncomfortable 13 (92.86%) 12 (92.31%) 12 (92.31%) 10 (76.92%) 10 (76.92%) 7 (77.78%)
Outcome measurements were uncomfortable 0 (0%) 0 (0%) 0 (0%) 1 (7.69%) 1 (7.69%) 0 (0%)
Outcome measurements were not uncomfortable 3 3 5 2 4 2
NB: Just the results of the first 6 weeks are presented because this is when the majority of the participants completed the interventions.
MTS group: one participant completed the interventions within 4 weeks, nine in 5 weeks, 15 in 6 weeks, 18 in 7 weeks, and one took 9 weeks.
TI group: One participant withdrew after 1 week; four participants completed the interventions in 5 weeks, 12 in 6 weeks and all by 7 weeks.
MTS, Mobilization and tactile stimulation; TI, Textured insoles; TSGT, Task-specific gait training.
Sub-theme: Ending the Study
By the time the study finished, many participants had developed
sufficient movement and ability to undertake functional activities
unaided or with their families, and several participants
were demonstrating self-management skills. Nevertheless, some
participants felt disappointed and let down, when their
participation in the study ended, even describing a sense
of loss. There was a perception of having made good
progress during the study, but a sadness that the intervention
had ceased.
Acceptability and Feasibility of Outcome
Measures (Objective 4)
Outcome measures results indicate a decrease in modified
5MWT time from baseline to end of intervention and
improvements in the FAC, LEMI, and mRMI scores for both
groups, which were maintained at the 1-month follow-up
(Table 9).
A potential ceiling effect was noted for the mRMI results, with
34.21% of theMTS+TSGT group at both end of intervention and
1-month follow-up, and 7.69% of the TI+TSGT group at end of
intervention and 26.92% at 1-month follow-up reaching the full
35-point threshold.
During goniometer measurements, which required
participants to wear shoes, there was potential for movement
of the electrogoniometer within the shoe, affecting reliability of
the measurement.
Research assessors reported that measuring touch/pressure
sensory thresholds at four sites using the SWMs was very
time-consuming. They also reported that setting up, calibrating
and recording pressure insole measurements in multiple
locations (each participant’s home) was both challenging
and time-consuming.
In the MTS group no participants stated the outcome
measures were uncomfortable, and in the TI+TSGT group
only one participant reported that the outcome measures
were uncomfortable.
Success of Blinding
The blinded assessor guessed accurately the group allocation of
just three of the 32 participants completing the study: 9.38% (95%
CI 3.2%, 24.2%).
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MTS group: “Some parts of it were painful... sticking your thumb in” (Edward, FG3)
“Painful for the first couple of sessions, after that it was okay” (Evelyn, FG3)
TI group: “I felt surprised actually because when I first saw them I thought “oh dear
these are going to be prickly”, and they weren’t” (Olivia, FG 4)
“The textured one on the left foot, when you got used to it, it’s more comfortable than
the plain one” (Brian, FG 2)
“Once they was in the shoes they stopped there till I went to bed” (Isaac, FG 2)
“I transferred it from different shoes that I was wearing, I even put it in my slippers”
(Nadine, FG 2)
Challenges of TSGT Tiring: “I did need to rest afterwards” (Nancy, FG 3)
“I used to feel tired the next day” (Phoebe, FG 3)
Confidence building MTS group: “My wife isn’t the same as you standing there. You do give me
confidence...as soon as you dropped off, my confidence dropped” (Harry, FG 1)
“…gave me the confidence to go out, back out, and to walk with a stick” (Jackie, FG
3)
“…gave me confidence; you said to me one…one day “you’re going to walk now
without your stick”…I went from the kitchen into the living room, and I was REALLY
surprised at that!” (Harry, FG 1)
“Well, if it weren’t for that treatment I wouldn’t be walking now…My wife thinks the
same... if it wasn’t for you…I wouldn’t be walking now, I should be static” (Harry, FG 1)
“Where I would have gone down…now I find my balance a lot easier.” (Phoebe, FG 3)
TI group: “Having someone who knows what they’re talking about, that helps…with
confidence” (Olivia, FG 4)
“It’s helped me to achieve my goal and more, um, because I’m now trying things that I
wouldn’t have tried before...yes, it has absolutely without a doubt. I am even walking,
walking on my own now without a walking stick” (Nadine, FG 2)
“Knowing that I’d got control of my kneemeant there was no fear of falling, and I haven’t
fallen” (Henry, FG 2)
“Well, life after the trial has been good, because I’m able to get up and move about a
bit on my own, transfers…so I’m not a burden on somebody else” (Henry, FG 2)
Acceptability of the
outcome measures
Usefulness of feedback MTS group: “You showed me the clip of me walking three months ago and I couldn’t
believe it was me… it had changed dramatically how you’re moving; well, one was just
moving just through the room and, er it was quite remarkable to see the, the knee and
this walking” (Trevor, FG 1)
TI group: “I thought to myself this is measuring the outcome of the progress that I
have made and I was quite happy with that” (Nadine, FG 2)
“You know the pressure sensors that you put in the, er, in the shoes…and then on the
computer screen showing equal pressure on both feet I thought that was amazing”
(Henry, FG 2)
Safety “You’ve got to beware haven’t you, of tripping?” (Edgar, FG 4)
Overall study experience Intensive therapy at home MTS Group: “It was ideal. I felt more confident in my own surroundings… it gave you
the confidence to do that bit more because you were secure in your surroundings”
(Michelle, FG 3)
“Without you coming to the house, I don’t think I would have completed the course
because I would think ‘oh, it’s too much trouble to go and get ready and go out”’
(Jackie, FG 3)
“I would still have gone [to the hospital] …but it’s convenient you coming at home”
(Dennis, FG 3)
“I felt it was a bit …stressful, a bit ‘oh no, she’s coming again’… for it to be every day
it seemed too much” (Trevor, FG 1)
TI Group: “I felt comfortable because it was in my own house and felt as though I’d
got more control over it as well” (Nadine, FG 2)
“Many people are interfering with your life” (Frank, FG 1)
Ending the study MTS Group: “When it all finished I felt like, bloody hell, what am I going to do now?”
(Dennis, FG 3)
“It feels a whole lot better but I’m gutted you’ve left” (Evelyn, FG 3)
“I felt sorry it had finished because I felt it was doing me good” (Jackie, FG 3)
TI Group: “After the trial finished…I experienced a sense of loss” (Nadine, FG 2)
FG, Focus group; MTS, Mobilization and tactile stimulation; TIs, Textured insoles.
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TABLE 9 | Values for each outcome measure at baseline, end of intervention and 1 month follow-up.
Outcome measure Cost Group Baseline End of intervention 1-month follow-up
Modified 5MWT [seconds] None MTS Group 23.80; 26.82 (15.10)# 13.43; 16.86 (11.24) 11.41; 16.10 (13.82)
Median; mean (SD) TI Group 27.65; 35.41 (22.19)* 14.51; 21.56 (13.57)* 14.79; 21.28 (12.55)*
FAC [Scored from 0 to 5] None MTS Group 3; 2.37 (1.42) 4; 3.74 (0.87) 4; 4.26 (0.73)
Median; mean (SD) TI Group 2; 2.00 (1.51) 4; 3.92 (0.86)* 4; 4.15 (0.69)*
LEMI [Scored from 0 to 100] None MTS Group 76; 72.74 (20.99) 86; 83.95 (14.89) 92; 87.26 (16.31)
Median; mean (SD) TI Group 76; 60.50 (28.79)# 84; 75.85 (25.98)* 84; 76.01 (23.93)*
Ankle ROM [degrees] Electro-goniometer MTS group maximum dorsiflexion 9.9; 10.37 (6.01)* 9.85; 11.83 (9.02)# 8.5; 9.51 (6.27)#
Median; mean (SD) £4,611 TI group maximum dorsiflexion 9.45; 10.05 (5.10)† 10.10; 9.67 (3.47)† 5.80; 7.57 (3.77)††
MTS group maximum inversion 8.30; 8.48 (3.96)† 6.15; 7.78 (4.74)# 8.20; 8.26 (4.45)#
TI group maximum inversion 7.0; 7.44 (4.36)† 7.70; 9.01 (3.63)† 6.10; 7.33 (5.12)†
Sensory threshold testing Semmes MTS Group Heel 6; 8.00 (4.14)# 10.5; 10.17 (5.22)# 10.5; 8.79 (4.45)
(contralesional) Weinstein Hallux 10.5; 10.56 (5.06)# 10.5; 12.44 (3.99)# 11; 10.47 (4.64)
Median; mean (SD) monofilaments 1st MTP 11; 11.17 (3.55)# 12.5; 11.89 (4.75)# 11.5; 11.84 (4.31)
[Scored 1–20] £240 5th MTP 10; 10.32 (4.45) 14.5; 13.39 (4.13)# 13; 12.47 (3.95)
TI Group Heel 4; 5.23 (3.24)* 4; 7.45 (4.63)†† 4; 6.42 (4.44)†
Hallux 5; 7.25 (4.22)† 12; 11.45 (4.39)†† 9; 9.50 (4.66)†
1st MTP 6; 7.55 (2.94)†† 10; 10.64 (5.84)†† 10; 9.50 (6.24)†

















Centre of force (AP) velocity MTS Group 3.60; 4.29 (3.69) 4.70; 5.35 (3.79) 5.60; 5.71 (4.89)#
Median; mean (SD) [cm/sec] TI Group 1.90; 3.30 (3.56)# 3.40; 4.05 (3.33)* 1.80; 3.84 (3.89)*
mRMI [Scored from 0 to 40] MTS group to ipsilesional side 33; 30.29 (4.83)* 34; 33.53 (2.21)* 34; 34.22 (0.81)#
Median; mean (SD) TI group to ipsilesional side 23.5; 24.75 (7.62)† 34; 32.50 (3.21)††† 34; 33.08 (2.15)†
MTS group to contralesional side 33; 29.53 (5.82)* 34; 33.47 (3.30)* 34; 34.00 (1.11)#
TI group to contralesional side 24.5; 25.25 (7.34)† 34; 32.20 (3.58)††† 34; 32.75 (2.38)†
#One missing value, *Two missing values, †Three missing values, ††Four missing values, †††Five missing values.
AP, Anterior-posterior; FAC, Functional Ambulation Category; LEMI, Lower Extremity Motricity Index; mRMI, modified Rivermead Mobility Index; MTS, Mobilization and tactile stimulation;
ROM, Range of movement; SD, Standard deviation; TI, Textured insoles; TSGT, Task-specific gait training; 5MWT, 5 metre walk test.
Sample Size Calculation (Objective 5)
The required sample size for a main trial, assuming a minimum
clinically important difference of 9.6m/min on the modified
5MWT (81), 90% power, a two-tailed 5% significance level and
equal allocation, would be 51 per group. As small studies may
underestimate the standard deviation (82), the observed standard
deviation of 12.23 in the current study was inflated by a factor
of 1.21 so as to be 90% confident of achieving the nominal
power in the main trial (83). Assuming 15% loss to follow up,
60 participants per group would be required.
Serious Adverse Events, Adverse Events,
and Adverse Reactions (Objective 6)
Twenty-seven adverse events were recorded, 14 from the
MTS+TSGT group and 13 from the TI+TSGT group. These
consisted of: falls (n = 16), back pain (n = 2), neck pain (n
= 1), ipsilesional heel pain (n = 1), viral infection (n = 1),
atrial fibrillation (n = 1), pressure sore (n = 1), scratch on
dorsum of foot (n = 1), tiredness with swollen painful ankles
(n = 1), urinary tract infection (n = 1), hip and knee pain (n
= 1). These events were considered by an independent assessor,
in accordance with Good Clinical Practice (84) and Standard
Operating Procedures for Norwich Clinical Trials Unit and Keele
University, and all deemed unrelated to the study. There were
no adverse reactions to the interventions or outcome measures.
There were three unrelated serious adverse events (one further
stroke, and two hospital admissions).
Pilot Study Aspects to Inform a Future Trial
The traffic light system (78, 79) indicating which aspects of the
study should be taken forward is presented in Table 10.
DISCUSSION
This pilot study estimated the recruitment rate to a subsequent
effectiveness trial as 48.57% of stroke survivors screened
(objective 1) and the attrition rate as 5.88% (objective 2). The
adherence rate to the interventions was 96.88%, ranging between
94.74 and 100%, and the interventions and outcome measures
were found to be acceptable to participants (objective 3). The
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TABLE 10 | Planning a future trial: pilot study aspects considered within a traffic light system.
Traffic light Aspect of pilot study Considerations/changes required
Outcome measures mRMI—Ceiling effect evident and access to stairs issues—not meeting requirements of next trial.
Ankle range of movement with electrogoniometry—not to be used unless there is further reliability
testing. It is inappropriate to measure just the ankle range of movement and not the knee. Use of the
tibia to vertical angle (85) may be more clinically useful and could be piloted for further studies.
Study Management Group This worked well, but independent steering and data monitoring committees required in future.
Case report forms Consider electronic case report forms for future trials.
Recruitment procedures Consider involvement of Clinical Research Network to assist in recruitment for future studies.
Exclusion criteria Consider whether botulinum toxin should be an exclusion to the trial or not.
NIHSS Score four points less for left hemisphere stroke than right; NIHSS useful; staff training is essential.
Randomization procedures Consider issue of posterior circulation strokes for randomization in future trial.
Monitoring length of time
wearing TIs
Consider mechanism for recording the length of time TIs are worn if no daily diaries.
Outcome measures LEMI—suitable and quick to administer, must specify removal of footwear prior to testing.
Functional Ambulation Category—Consider access to stairs and inclines for accurate scoring.
Pressure insoles—Consider purchasing a wireless system to increase the safety of participants and
speed of testing. Need to build in time for setting up the equipment and calibrating the insoles.
Sensory threshold testing with SWMs—Due to the lack of significant results for all but the hallux point in
the TI group and time to test, consider applicability for future trials or just test one point.




The PPIE within MoTaStim-Foot was thorough and beneficial; plan this level of PPIE in future.
Screening Step test: This worked well, screening out stroke survivors who functioned at too high a level.
Ability to follow simple commands screening test: This served its purpose. All participants recruited had
capacity to consent and follow therapy instructions.
Interventions Thorough training is required for research therapists to ensure adherence all intervention protocols.
5MWT or 10MWT Video enabled assessment of assistance to walk/aide. Plan: 1–2m at start and end of the
5MWT/10MWT.
Blinded Assessment This worked well and should be continued for future trials.
Usual care therapy
treatment record
It is important to keep a record of the NHS therapy intervention received.
Pain/fatigue assessment
process and form
This is important to use to monitor pain and fatigue.
Focus groups exploring
participants’ perceptions
Hearing participants’ opinions is important in a therapy trial because they play an active part in
rehabilitation. It also allows for triangulation of methods.
Focus group schedules Will need to be adapted as required for a future trial.
LEMI, Lower Extremity Motricity Index; NIHSS, National Institutes of Health Stroke Scale; mRMI, modified Rivermead Motricity Index; NHS, National Health Service; PPIE, Patient and
public involvement and engagement; SWMs, Semmes Weinstein monofilaments; TIs, Textured insoles; 5 or 10MWT, 5 or 10 metre walk test. Red = Should not be retained; Amber =
Can be retained with some changes; Green = Can be retained without changes.
selected outcomemeasures, which were chosen with all aspects of
the ICF in mind, measured sensorimotor impairment and lower-
limb function and balance, and were delivered with a successful
blinding procedure and were acceptable to all 32 participants
who completed the study (objective 4). The estimated variance of
outcome measures was used to inform a sample size calculation
for a subsequent effectiveness trial (objective 5). No adverse
events or reactions that occurred were considered to result from
participation in the study (objective 6). Consequently, this pilot
study was successful at establishing feasibility of a subsequent
pragmatic trial.
The recruitment rate of 48.57% compares well with that of
other rehabilitation trials, for example: FAST-INdICATE 5.7%
(86); FeSTivaLS 4.6% (87); SWIFT-cast 4.59% (88). However, in
our pilot study the number of eligible patients was ascertained
from the number referred from the clinical team for screening,
and not the total number of stroke patients through the service.
In addition, our study included people with posterior circulation
as well as anterior circulation stroke. Furthermore, recruitment
early post-stroke enabled accrual through hospital services,
whereas FeSTivaLS recruited stroke survivors ∼2 years after
stroke from the community. All of these factors potentially
increased the recruitment rate for our pilot study compared with
earlier trials.
The attrition rate of 5.88% at both outcome and follow-up
also compares favourably with earlier trials; for example, the
attrition rate at end of intervention (12.5%) and at follow-up
(27.8%) for FAST INdiCATE (86) and end of intervention and
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follow-up (both 15.5%) in FeSTivaLS (87). As reported, the later
recruitment time post-stroke for the FeSTivaLS trial and the
longer follow-up time (6 months) in the FAST-INdiCATE trial
may have accounted for some of the difference in findings in
comparison with our study. The relatively small sample size, and
the fact that the study was only undertaken at one site, may also
have contributed to this low attrition rate.
An adherence (delivery of interventions to protocol) rate
of 96.88% [94.74% (MTS)−100% (TIs)] compares favourably
with earlier trials, for example in FeSTivaLS where only 65%
of participants completed the full complement of functional
strength training for the lower limb. The issues stated above
may have contributed to this higher value; however, another key
aspect was that in the FeSTivaLS trial each intervention lasted
for 1 hour, whereas in MoTaStim-Foot each TSGT session lasted
half an hour. Another trial, which also delivered 30min of task-
orientated training to improve lower-limb strength, reported
100% adherence (89).
Acceptability involves many different aspects, including: an
ability to understand the intervention; participants’ perceived
ability to participate (self-efficacy); their perceptions of the
intervention and its usefulness; burden, including necessary
compromises to enable participation; and congruence of the
intervention with the participant’s value system (90). Participants
in this study confirmed that both the textured and smooth
insoles were acceptable and comfortable, and the physical
characteristics (density, peak height, and distribution) of the TIs
used were acceptable for further study with stroke survivors, with
participants able to perceive the TI underfoot and differentiate
between a textured and smooth insole. The lack of adverse
reactions supports the suitability of using MTS and bespoke TIs
as interventions in the future.
Objective 4 included identifying a primary outcome measure
for future trials (91). All outcomes were assessed at baseline,
end of intervention, and 1-month follow-up, and just the
LEMI and SWMs measured more frequently, after 5, 10, and
15 treatments, enabling close monitoring of potential changes
to inform intervention dose for a future trial. Selection of
the primary and secondary outcome measures for the future
trial considered many aspects. This included addressing the
different ICF domains, validity, reliability, and responsiveness
to change, as well as potential floor or ceiling effects, how
feasible it was to undertake the different outcome measures, and
their acceptability.
Of the measures used in this trial, we considered the modified
5MWT to be the most appropriate primary outcome measure for
a future trial: it is reliable (92), responsive to change in walking
ability after stroke (58), clinically relevant, quick and easy to set
up, and demonstrated potential for change. It provides ratio-
level data, has no ceiling or floor effect limitations, and incurs
negligible costs. However, to enable improved standardisation
of procedure for future trials, a larger space in an appropriate
location, such as a university laboratory or hospital setting,
should be used rather than the limited space in participants’
homes, which does not allow for the recommended 2–3m (55,
92) for acceleration and deceleration. Further consideration will
also be given to the 10MWT or 6-min walk, as advocated by
the Stroke Recovery and Rehabilitation Roundtable guidelines for
stroke research (66).
For secondary outcome measures to take forward, we selected
the LEMI, which is a valid and reliable measure of motor
impairment (56, 57) and responsive to change (Table 9), and the
FAC, also valid and reliable for classifying functional ability for
a stroke population (52), quick to undertake, and responsive to
change (Table 9).
A ceiling effect was evident from the mRMI data (93), with
median scores of 34 (out of a maximum of 35) in each of the
categories at end of intervention and follow-up for both groups.
Restricted access to or absence of stairs in participants’ homes
was an additional limitation of the mRMI. Consequently, we did
not consider the mRMI to be a suitable outcome measure for a
larger trial.
We found that potential movement of the electrogoniometer
within the shoe may have affected reliability and validity of the
goniometry data.Whilst this has not been identified as a potential
issue by the manufacturer, further investigation of reliability
needs to be done before including this in a larger trial.
Touch/pressure sensory threshold testing at four different sites
on the plantar surface of the foot was time-consuming. Repeated
testing has potential either to increase testing fatigue and reduce
attention to the task and, therefore, reliability, or to enhance
sensibility of subsequent testing sites by raising awareness of the
foot as a whole. Despite using a bespoke algorithm for SWM
testing in this study (Supplementary Material), which decreased
the burden of testing for participants by reducing the number of
filaments used at each location, we need to consider further the
choice and number of testing sites. Testing just one site may be
sufficient, particularly if that one site indicates either fully intact
or absent sensation (94); if sensation at one site is affected, it is
likely that all sites will be affected, due to stroke being an upper
motor neurone lesion.
Furthermore, assessment of cutaneous touch/pressure
thresholds from the plantar surface of the foot in a non-
weight-bearing position may not appropriately reflect afferent
information received in an upright standing posture. Afferent
information from ankle proprioceptors may decrease the
importance of cutaneous afferent information from the plantar
surface of the foot during balance (95). Impaired proprioception
post-stroke is more prevalent than tactile sensory impairment
(96) and alignment of the foot and ankle is important to
enable normal balance and gait. Although MTS provides tactile
information through the cutaneous afferents, an important
aim is to provide intensive proprioceptive stimulation (12).
Consequently, measurement of proprioception, using the
Erasmus version of the Nottingham Sensory Assessment or the
sensory section of the Fugl–Meyer Assessment, advocated with
careful standardised testing procedures (68), will be considered
prior to the next trial.
The challenges relating to setting up and calibrating pressure
insoles should be factored into planning the burden of assessment
if these insoles are to be included in future studies. Extreme care
was necessary to ensure participants’ safety, due to the long wires;
a wireless system is advised. The additional cost implications
need to be considered.
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The perceived sense of loss reported in relation to termination
of the study needs to be borne in mind for subsequent
rehabilitation trials; participants should be adequately supported.
Limitations of This Pilot Study
Undertaking this study at one site, which had been involved
in other trials involving MTS and other therapy interventions,
may have introduced bias through prior familiarity with the
intervention and the research team.
The sample size for our study was the largest achievable within
available resources, and whilst smaller than that recommended
for estimates of binary outcomes (97), it was broadly in line with
recommendations for continuous outcomes (40, 41).
Strengths of This Pilot Study
The sample was representative of the stroke population for
age, gender, and type of stroke when comparing with other
rehabilitation trials (86–88); the small sample size would account
for slight discrepancies.
The study followed the guidance in the CONSORT 2010
statement extension to randomized pilot and feasibility trials (75,
98) and the psychometric properties of the outcome measures
informed their selection. Research therapists and assessors
were appropriately trained, and standardised procedures and
protocols were followed for delivering interventions and
undertaking outcome measures. Data collection triangulation,
by including both daily diaries and focus groups, increased
credibility within the study (99).
The value of PPIE in health research has been increasingly
recognised, with the NIHR and stroke research networks
embracing strategies to increase PPIE input (100). Involvement
of PPIE volunteers at all stages of the MoTaSTim-Foot pilot
study from initial stages through to dissemination at the
UK Stroke Forum, with involvement in almost every aspect
of the study, was an important strength. The inclusion
of an additional member of the research team (a stroke
survivor, a PPIE volunteer) as observer and field-note
taker during the focus groups enabled additional insights
and an appreciation of the context behind the participants’
dialogue, reducing the potential bias associated with a single
investigator (101).
CONCLUSION
This study has successfully provided feasibility information in
preparation for a subsequent RCT, suggesting that the subsequent
trial will have a high recruitment and low attrition rate, excellent
adherence to the experimental and control interventions,
and that these interventions and outcome measures will
be acceptable to stroke survivors with no expected adverse
reactions. We can conclude that a larger RCT is feasible
and should have a nominal sample size of 60 participants
per group based on the modified 5MWT as the primary
outcome measure.
However, prior to undertaking a definitive clinical trial,
further consideration will be given to whether the trial can
be delivered successfully in other regions, the optimal dose of
intervention and most appropriate target population and time
post stroke, in accordance with the second Stroke Recovery and
Rehabilitation Roundtable recommendations (53).
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by UK National Research Ethics Service (4/3/16), IRAS
No: 171968/REC Ref 16/WM/0080. The patients/participants
provided their written informed consent to participate in
this study.
AUTHOR CONTRIBUTIONS
AMA, JS, SMH, and VMP developed the statistical analysis
plan. AMA and SMH checked the quantitative database for
accuracy, exported the data for statistical analysis, analyzed
the daily diaries, and drafted the manuscript. AMA, SMH,
and JS performed the statistical analyses. AMA, SMH, and SR
undertook the thematic analysis of the focus groups. AMA
was Chief Investigator for the MoTaStim-Foot pilot study, with
supervision from SMH, VMP, JS, and SR. All authors revised
the manuscript for important intellectual content, read and
approved the final manuscript, and participated in the design of
the study.
FUNDING
AMA was funded by a National Institute for Health Research
(NIHR), Clinical Academic Doctoral Fellowship for this research
project. This report is independent research supported by the
National Institute for Health Research (NIHR/HEE CAT Clinical
Doctoral Research Fellowship, Mrs Alison Aries, CDRF-2014-05-
065). The views expressed in this publication are those of the
author(s) and not necessarily those of the NHS, the National
Institute for Health Research or the Department of Health. VMP
was supported by the National Institute for Health Research
(NIHR) Brain Injury MedTech Co-operative based at Cambridge
University Hospitals NHS Foundation Trust and University
of Cambridge.
ACKNOWLEDGMENTS
The authors would like to thank Norwich Clinical Trials Unit
for all their support with the development and running of
MoTaStim-Foot; particular thanks go to Dr. Erika Sims for her
patience and dedication when developing the detailed protocol
for the study. Also, our thanks go to the staff within Research
Governance at Keele University for their support throughout
the study; to Carole Watkins for providing an independent
assessment of the adverse events within the study; Emily
Frontiers in Neurology | www.frontiersin.org 21 July 2021 | Volume 12 | Article 675106
Aries et al. MoTaStim-Foot: A Pilot Study
Samuels and Charlie Hancox for assisting with the analysis
of the data related to the interventions and conventional
therapy; Dr. Dimitra Blana for assisting with extraction of
the electrogoniometer results; and Robert Bradshaw-Hilditch
for helping with the preparation of the textured insoles. We
would also like to thank the participants of the study and
the research therapists. Finally, the work of all the patient
and public involvement and engagement volunteers must be
acknowledged. Particular thanks go to Paul Bailey for his
commitment throughout the study, help running the focus
groups and also for presenting the work at the UK Stroke Forum
with AMA.
SUPPLEMENTARY MATERIAL




1. Stroke-Association. State of the Nation - Stroke Statistics. Stroke





2. Feigenson JS, McCarthy ML, Meese PD, Feigenson WD, Greenberg SD,
Rubin E, et al. Stroke rehabilitation I. Factors predicting outcome and length
of stay-an overview. N Y State J Med. (1977) 77:1426–30.
3. Kim JS, Choi-Kwon S. Discriminative sensory dysfunction after unilateral
stroke. Stroke. (1996) 27:677–82. doi: 10.1161/01.STR.27.4.677
4. Carey LM. Stroke Rehabilitation Insights From Neuroscience and Imaging.
Oxford: Oxford University Press (2012).
5. Tyson SF, Crow JL, Connell L, Winward C, Hillier S. Sensory impairments
of the lower limb after stroke: a pooled analysis of individual patient data.
Topics Stroke Rehabil. (2013) 20:441–9. doi: 10.1310/tsr2005-441
6. Gorst T, Rogers A, Morrison SC, Cramp M, Paton J, Freeman J, et al.
The prevalence, distribution, and functional importance of lower
limb somatosensory impairments in chronic stroke survivors: a cross
sectional observational study. Disabil Rehabil. (2018) 41:2433–50.
doi: 10.1080/09638288.2018.1468932
7. Patel AT, Duncan PW, Lai S, Studenski S. The relation between impairments
and functional outcomes poststroke.Arch PhysMed Rehabil. (2000) 81:1357–
63. doi: 10.1053/apmr.2000.9397
8. Sánchez-Blanco I, Ochoa-Sangrador C, López-Munain L, Izquierdo-Sánchez
M, Fermoso-Garcia J. Predictive model of functional independence in
stroke patients admitted to a rehabilitation programme. Clin Rehabil. (1999)
13:464–75. doi: 10.1191/026921599672994947
9. Pollock A, St George B, Fenton M, Firkins L. Top 10 research
priorities relating to life after stroke–consensus from stroke survivors,
caregivers, and health professionals. Int J Stroke. (2014) 9:313–20.
doi: 10.1111/j.1747-4949.2012.00942.x
10. Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann
K, et al. Agreed definitions and a shared vision for new standards in
stroke recovery research: the stroke recovery and rehabilitation roundtable
taskforce. Int J Stroke. (2017) 12:444–50. doi: 10.1177/1747493017711816
11. Pomeroy V, Aglioti SM, Mark VW, McFarland D, Stinear C, Wolf
SL, et al. Neurological principles and rehabilitation of action disorders:
rehabilitation interventions.Neurorehabil Neural Repair. (2011) 25:33S−43S.
doi: 10.1177/1545968311410942
12. Hunter SM, Crome P, Sim J, Donaldson C, Pomeroy VM. Development
of treatment schedules for research: a structured review to identify
methodologies used and a worked example of ‘mobilisation and tactile
stimulation’ for stroke patients. Physiotherapy. (2006) 92:195–207.
doi: 10.1016/j.physio.2006.01.001
13. Hunter SM, Crome P, Sim J, Pomeroy VM. Effects of mobilization and
tactile stimulation on recovery of the hemiplegic upper limb: a series of
replicated single-system studies. Arch Phys Med Rehabil. (2008) 89:2003–10.
doi: 10.1016/j.apmr.2008.03.016
14. Winter JM, Crome P, Sim J, Hunter SM. Effects of mobilization and
tactile stimulation on chronic upper-limb sensorimotor dysfunction after
stroke. Arch Phys Med Rehabil. (2013) 94:693–702. doi: 10.1016/j.apmr.2012.
11.028
15. Hillier S, Dunsford A. A pilot study of sensory retraining for the
hemiparetic foot post-stroke. Int J Rehabil Res. (2006) 29:237–42.
doi: 10.1097/01.mrr.0000210052.32539.22
16. Aries AM, Cooke L, Hunter S. Mobilization and tactile (sensory) stimulation
(mts) for the foot post stroke: opinions and perceptions of expert clinicians.
Int J Ther Rehabil. (2019) 26:15. doi: 10.12968/ijtr.2019.26.6.15
17. Orth D, Davids K, Wheat J, Seifert L, Liukkonen J, Jaakkola T, et al. The role
of textured material in supporting perceptual-motor functions. PLoS ONE.
(2013) 8:e60349. doi: 10.1371/journal.pone.0060349
18. Christovão T, Neto H, Grecco L, Ferreira L, de Moura R, de Souza M, et al.
Effect of different insoles on postural balance: a systematic review. J Phys
Ther Sci. (2013) 25:1353–6. doi: 10.1589/jpts.25.1353
19. Cruz-Almeida Y, Black ML, Christou EA, Clark DJ. Site-specific
differences in the association between plantar tactile perception and
mobility function in older adults. Front Aging Neurosci. (2014) 6:68.
doi: 10.3389/fnagi.2014.00068
20. Kavounoudias A, Roll R, Roll J-P. The plantar sole is a ’dynamometric
map’ for human balance control. Neuroreport. (1998) 9:3247–52.
doi: 10.1097/00001756-199810050-00021
21. Ribot-Ciscar E, Vedel JP, Roll JP. Vibration sensitivity of slowly and rapidly
adapting cutaneous mechanoreceptors in the human foot and leg. Neurosci
Lett. (1989) 104:130–5. doi: 10.1016/0304-3940(89)90342-X
22. Smania N, Montagnana B, Faccioli S, Fiaschi A, Aglioti SM. Rehabilitation
of somatic sensation and related deficit of motor control in patients
with pure sensory stroke. Arch Phys Med Rehabil. (2003) 84:1692–702.
doi: 10.1053/S0003-9993(03)00277-6
23. Raine S, Meadows L, Lynch-Ellerington M. Bobath Concept: Theory
and Clinical Practice in Neurological Rehabilitation. Chichester: Blackwell
Publishing (2009).
24. Hatton AL, Dixon J, RomeK,Martin D. Standing on textured surfaces: effects
on standing balance in healthy older adults. Age Ageing. (2011) 40:363–8.
doi: 10.1093/ageing/afr026
25. Dixon J, Hatton AL, Robinson J, Gamesby-Iyayi H, Hodgson D, Rome
K, et al. Effect of textured insoles on balance and gait in people with
multiple sclerosis: an exploratory trial. Physiotherapy. (2014) 100:142–9.
doi: 10.1016/j.physio.2013.06.003
26. Veerbeek JM, van Wegen E, van Peppen R, van der Wees PJ, Hendriks E,
Rietberg M, et al. What is the evidence for physical therapy poststroke?
A systematic review and meta-analysis. PLoS ONE. (2014) 9:e87987.
doi: 10.1371/journal.pone.0087987
27. French B, Thomas LH, Coupe J, McMahon NE, Connell L, Harrison
J, et al. Repetitive task training for improving functional ability
after stroke. Cochrane Database Syst Rev. (2016) 11:CD006073.
doi: 10.1002/14651858.CD006073.pub3
28. Rudd A, Bowen A, Young G, James M. The latest national clinical
guideline for stroke: 5th edition. Clin Med. (2017) 17:154–5.
doi: 10.7861/clinmedicine.17-2-154
29. Salbach NM, Mayo NE, Wood-Dauphinee S, Hanley JA, Richards CL, Côté
R. A task-orientated intervention enhances walking distance and speed in
the first year post stroke: a randomized controlled trial. Clin Rehabil. (2004)
18:509–19. doi: 10.1191/0269215504cr763oa
Frontiers in Neurology | www.frontiersin.org 22 July 2021 | Volume 12 | Article 675106
Aries et al. MoTaStim-Foot: A Pilot Study
30. Dean CM, Richards CL, Malouin F. Task-related circuit training improves
performance of locomotor tasks in chronic stroke: a randomized,
controlled pilot trial. Arch Phys Med Rehabil. (2000) 81:409–17.
doi: 10.1053/mr.2000.3839
31. French B, Leathley M, Sutton C, McAdam J, Thomas L, Forster A, et al. A
systematic review of repetitive functional task practice with modelling of
resource use, costs and effectiveness. Health Technol Assess. (2008) 12:iii.
doi: 10.3310/hta12300
32. Rossignol S, Dubuc R, Gossard J-P. Dynamic sensorimotor interactions in
locomotion. Physiol Rev. (2006) 86:89–154. doi: 10.1152/physrev.00028.2005
33. Laaksonen K, Kirveskari E, Mäkelä JP, Kaste M, Mustanoja S,
Nummenmaa L, et al. Effect of afferent input on motor cortex
excitability during stroke recovery. Clin Neurophysiol. (2012) 123:2429–36.
doi: 10.1016/j.clinph.2012.05.017
34. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew
M. Developing and Evaluating Complex Interventions: New Guidance.
(2006). Available online at: https://mrc.Ukri.Org/documents/pdf/complex-
interventions-guidance/ (accessed February 2, 2021).
35. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. (2011)
377:1693–702. doi: 10.1016/S0140-6736(11)60325-5
36. Alexander MP. Stroke rehabilitation outcome. A potential use of
predictive variables to establish levels of care. Stroke. (1994) 25:128–34.
doi: 10.1161/01.STR.25.1.128
37. Clark L, Fairhurst C, Torgerson DJ. Allocation concealment in
randomised controlled trials: are we getting better? BMJ. (2016) 355:i5663.
doi: 10.1136/bmj.i5663
38. Hill KD, Bernhardt J, McGann AM, Maltese D, Berkovits D. A new
test of dynamic standing balance for stroke patients: reliability, validity
and comparison with healthy elderly. Physiother Can. (1996) 48:257–62.
doi: 10.3138/ptc.48.4.257
39. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on
pilot studies: the what, why and how. BMC Med Res Methodol. (2010) 10:1.
doi: 10.1186/1471-2288-10-1
40. Browne RH. On the use of a pilot sample for sample size determination. Stat
Med. (1995) 14:1933–40. doi: 10.1002/sim.4780141709
41. Pomeroy VM, Cooke E, Hamilton S, Whittet A, Tallis RC. Development
of a schedule of current physiotherapy treatment used to improve
movement control and functional use of the lower limb after stroke: a
precursor to a clinical trial. Neurorehabil Neural Repair. (2005) 19:350–9.
doi: 10.1177/1545968305280581
42. Aries AM. Somatosensory stimulation to improve lower-limb recovery
after stroke (PhD Thesis). Keele University, Newcastle-under-Lyme,
Staffordshire (2020).
43. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al.
Better reporting of interventions: template for Intervention Description and
Replication (TIDieR) checklist and guide. Gesundheitswesen. (2016) 78:175–
88. doi: 10.1136/bmj.g1687
44. O’Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al.
Guidance on how to develop complex interventions to improve health and
healthcare. BMJOpen. (2019) 9:e029954. doi: 10.1136/bmjopen-2019-029954
45. Hunter SM, Hammett L, Ball S, Smith N, Anderson C, Clark A, et al. Dose-
response study of mobilisation and tactile stimulation therapy for the upper
extremity early after stroke: a phase 1 trial. Neurorehabil Neural Repair.
(2011) 25:314–22. doi: 10.1177/1545968310390223
46. Ballinger C, Ashburn A, Low J, Roderick P. Unpacking the black box of
therapy—a pilot study to describe occupational therapy and physiotherapy
interventions for people with stroke. Clin Rehabil. (1999) 13:301–9.
doi: 10.1191/026921599673198490
47. Watanabe I, Okubo J. The role of the plantar mechanoreceptor
in equilibrium control. Ann N Y Acad Sci. (1981) 374:855–64.
doi: 10.1111/j.1749-6632.1981.tb30926.x
48. Kennedy PM, Inglis JT. Distribution and behaviour of glabrous cutaneous
receptors in the human foot sole. J Physiol. (2002) 538:995–1002.
doi: 10.1113/jphysiol.2001.013087
49. Corbin DM, Hart JM, Palmieri-Smith R, Ingersoll CD, Hertel J. The effect of
textured insoles on postural control in double and single limb stance. J Sport
Rehabil. (2007) 16:363–72. doi: 10.1123/jsr.16.4.363
50. Wiener J, Foley N, Peireira S, Cotoi A, Chow J, Janssen S, et al.
Mobility and the Lower Extremity. Ebrsr: Evidence-Based Review of stroke
Rehabilitation, Review of Stroke Rehabilitation. (2018). p. 1–191. Available
online at: http://www.Ebrsr.Com/evidence-review/9-mobility-and-lower-
extremity (accessed April 30, 2021).
51. Meyer BC, Lyden PD. The modified national institutes of health
stroke scale: its time has come. Int J Stroke. (2009) 4:267–73.
doi: 10.1111/j.1747-4949.2009.00294.x
52. Mehrholz J, Wagner K, Rutte K, Meissner D, Pohl M. Predictive
validity and responsiveness of the functional ambulation category in
hemiparetic patients after stroke. Arch Phys Med Rehabil. (2007) 88:1314–9.
doi: 10.1016/j.apmr.2007.06.764
53. Bernhardt J, Hayward KS, Dancause N, Lannin NA, Ward NS, Nudo
RJ, et al. A stroke recovery trial development framework: consensus-
based core recommendations from the second stroke recovery and
rehabilitation roundtable. Neurorehabil Neural Repair. (2019) 33:959–69.
doi: 10.1177/1545968319888642
54. Bronner S, Agraharasamakulam S, Ojofeitimi S. Reliability and validity
of a new ankle electrogoniometer. J Med Eng Technol. (2010) 35:350–5.
doi: 10.3109/03091902.2010.493968
55. Tracey EH, Greene AJ, Doty RL. Optimizing reliability and sensitivity
of semmes–weinstein monofilaments for establishing point tactile
thresholds. Physiol Behav. (2012) 105:982–6. doi: 10.1016/j.physbeh.2011.
11.002
56. Cameron D, Bohannon RW. Criterion validity of lower
extremity motricity index scores. Clin Rehabil. (2000) 14:208–11.
doi: 10.1191/026921500675786655
57. Fayazi M, Dehkordi SN, Dadgoo M, Salehi M. Test-retest reliability of
motricity index strength assessments for lower extremity in post stroke
hemiparesis.Med J Islamic Republic Iran. (2012) 26:27–30.
58. Salbach NM, Mayo NE, Higgins J, Ahmed S, Finch LE, Richards CL.
Responsiveness and predictability of gait speed and other disability
measures in acute stroke. Arch Phys Med Rehabil. (2001) 82:1204–12.
doi: 10.1053/apmr.2001.24907
59. Low DC, Dixon SJ. Footscan pressure insoles: accuracy and reliability of
force and pressure measurements in running. Gait Posture. (2010) 32:664–6.
doi: 10.1016/j.gaitpost.2010.08.002
60. Chesnin KJ, Selby-Silverstein L, Besser MP. Comparison of an in-
shoe pressure measurement device to a force plate: concurrent validity
of center of pressure measurements. Gait Posture. (2000) 12:128–33.
doi: 10.1016/S0966-6362(00)00071-0
61. Lennon S, Johnson L. The modified rivermead mobility
index: validity and reliability. Disabil Rehabil. (2000) 22:833–9.
doi: 10.1080/09638280050207884
62. Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied
Research. Thousand Oaks, CA: Sage Publications, Inc. (2000).
63. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol.
(2006) 3:77–101. doi: 10.1191/1478088706qp063oa
64. World Health Organization (WHO).How to Use the ICF: A Practical Manual
for Using the International Classification of Functioning, Disability and
Health (ICF). Exposure draft for comment. Geneva: WHO (2013). Available
online at: https://cdn.who.int/media/docs/default-source/classification/icf/
drafticfpracticalmanual2.pdf?sfvrsn=8a214b01_4 (accessed April 24, 2021).
65. Sim J, Wright C. Research in Health Care: Concepts, Designs and Methods.
Cheltenham: Stanley Thornes (2000).
66. Kwakkel G, Lannin NA, Borschmann K, English C, Ali M, Churilov
L, et al. Standardized measurement of sensorimotor recovery in stroke
trials: consensus-based core recommendations from the stroke recovery and
rehabilitation roundtable. Neurorehabil Neural Repair. (2017) 31:784–92.
doi: 10.1177/1545968317732662
67. Moriguchi CS, Sato TO, Coury HJCG. Ankle movements during normal gait
evaluated by flexible electrogoniometer. / Movimentos do tornozelo durante
a marcha normal avaliados por eletrogoniometria flexível. Brazil J Phys Ther.
(2007) 11:205–11. doi: 10.1590/S1413-35552007000300006
68. Connell LA, Tyson SF. Measures of sensation in neurological
conditions: a systematic review. Clin Rehabil. (2012) 26:68–80.
doi: 10.1177/0269215511412982
Frontiers in Neurology | www.frontiersin.org 23 July 2021 | Volume 12 | Article 675106
Aries et al. MoTaStim-Foot: A Pilot Study
69. Suzuki K, Nakamura R, Yamada Y, Handa T. Determinants of maximum
walking speed in hemiparetic stroke patients. Tohoku J Exp Med. (1990)
162:337–44. doi: 10.1620/tjem.162.337
70. Jacelon CS, Imperio K. Participant diaries as a source of data
in research with older adults. Qual Health Res. (2005) 15:991–7.
doi: 10.1177/1049732305278603
71. McMahon SA, Winch PJ. Systematic debriefing after qualitative encounters:
an essential analysis step in applied qualitative research. BMJ Global Health.
(2018) 3:e000837. doi: 10.1136/bmjgh-2018-000837
72. Fischer CT. Bracketing in qualitative research: conceptual and practical
matters. Psychother Res. (2009) 19:583–90. doi: 10.1080/1050330090279
8375
73. Copeland D, Liska H. Implementation of a post-code pause: extending
post-event debriefing to include silence. J Trauma Nurs. (2016) 23:58–64.
doi: 10.1097/JTN.0000000000000187
74. Sim J. Should treatment effects be estimated in pilot and feasibility
studies? Pilot Feasibility Stud. (2019) 5:107. doi: 10.1186/s40814-019-
0493-7
75. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L.
Consort 2010 statement: extension to randomised pilot and feasibility trials.
BMJ. (2016) 355:1–29. doi: 10.1186/s40814-016-0105-8
76. Krippendorff K. Content Analysis: An Introduction to Its Methodology, 3rd
ed. Thousand Oaks, CA: Sage Publications (2013).
77. Ziebland S, McPherson A. Making sense of qualitative data
analysis: an introduction with illustrations from dipex (personal
experiences of health and illness). Med Educ. (2006) 40:405–14.
doi: 10.1111/j.1365-2929.2006.02467.x
78. ICO. Guide to the General Data Protection Regulation (GDPR). Information
Commissioner’s Office (2020). Available online at: https://ico.org.uk/
for-organisations/guide-to-data-protection/guide-to-the-general-data-
protection-regulation-gdpr/ (accessed February 2, 2021).
79. Tilson JK, Sullivan KJ, Cen SY, Rose DK, Koradia CH, Azen SP, et al.
Meaningful gait speed improvement during the first 60 days poststroke:
minimal clinically important difference. Phys Ther. (2010) 90:196–208.
doi: 10.2522/ptj.20090079
80. Vickers AJ. Underpowering in randomized trials reporting a
sample size calculation. J Clin Epidemiol. (2003) 56:717–20.
doi: 10.1016/S0895-4356(03)00141-0
81. Sim J, LewisM. The size of a pilot study for a clinical trial should be calculated
in relation to considerations of precision and efficiency. J Clin Epidemiol.
(2012) 65:301–8. doi: 10.1016/j.jclinepi.2011.07.011
82. Bhatt A. International council for harmonisation e6(r2) addendum:
challenges of implementation. Perspect Clin Res. (2017) 8:162–6.
doi: 10.4103/picr.PICR_124_17
83. Sheron N, Moore M, Ansett S, Parsons C, Bateman A. Developing a
’traffic light’ test with potential for rational early diagnosis of liver fibrosis
and cirrhosis in the community. Br J General Prac. (2012) 62:616–24.
doi: 10.3399/bjgp12X654588
84. Meijel B, Hamersveld S, Gool R, der Bijl J, Harten P. Effects and feasibility
of the ’traffic light method for somatic screening and lifestyle’ in patients
with severe mental illness: a pilot study. Perspect Psychiatric Care. (2015)
51:106–13. doi: 10.1111/ppc.12071
85. Kerr A, Rowe P, Clarke A, Chandler E, Smith J, Ugbolue C, et al.
Biomechanical correlates for recovering walking speed early after stroke. Is
the tibia to vertical angle a distinctive therapy target? Gait Posture. (2019)
73:277–8. doi: 10.1016/j.gaitpost.2019.07.150
86. Hunter SM, Johansen-Berg H, Ward N, Kennedy NC, Chandler E, Weir CJ,
et al. Functional strength training and movement performance therapy for
upper limb recovery early poststroke-efficacy, neural correlates, predictive
markers, and cost-effectiveness: fast-indicate trial. Front Neurol. (2018)
8:733. doi: 10.3389/fneur.2017.00733
87. Mares K, Cross J, Clark A, Vaughan S, Barton GR, Poland F, et al. Feasibility
of a randomized controlled trial of functional strength training for people
between six months and five years after stroke: festivals trial. Trials. (2014)
15:1–11. doi: 10.1186/1745-6215-15-322
88. Pomeroy VM, Rowe P, Clark A, Walker A, Kerr A, Chandler E, et al. A
randomized controlled evaluation of the efficacy of an ankle-foot cast on
walking recovery early after stroke: swift cast trial. Neurorehabil Neural
Repair. (2016) 30:40–8. doi: 10.1177/1545968315583724
89. Yang YR, Wang RY, Lin KH, Chu MY, Chan RC. Task-oriented progressive
resistance strength training improves muscle strength and functional
performance in individuals with stroke. Clin Rehabil. (2006) 20:860–70.
doi: 10.1177/0269215506070701
90. Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare
interventions: an overview of reviews and development of a theoretical
framework. BMC Health Serv Res. (2017) 17:88. doi: 10.1186/s12913-017-
2031-8
91. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies:
recommendations for good practice. J Eval Clin Prac. (2004) 10:307–12.
doi: 10.1111/j.0.2002.384.doc.x
92. Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: reliability of
measures of impairment and disability. Int Disabil Stud. (1990) 12:6–9.
doi: 10.3109/03790799009166594
93. Johnson L, Selfe J. Measurement of mobility following stroke: a comparison
of the modified rivermead mobility index and the motor assessment scale.
Physiotherapy. (2004) 90:132–8. doi: 10.1016/j.physio.2004.01.004
94. Busse M, Tyson SF. How many body locations need to be tested when
assessing sensation after stroke? An investigation of redundancy in the
rivermead assessment of somatosensory performance. Clin Rehabil. (2009)
23:91–5. doi: 10.1177/0269215508097296
95. Marigold DS, Eng JJ, Tokuno CD, Donnelly CA. Contribution of
muscle strength and integration of afferent input to postural instability
in persons with stroke. Neurorehabil Neural Repair. (2004) 18:222–39.
doi: 10.1177/1545968304271171
96. Connell LA, Lincoln NB, Radford KA. Somatosensory impairment after
stroke: frequency of different deficits and their recovery. Clin Rehabil. (2008)
22:758–67. doi: 10.1177/0269215508090674
97. Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ.
Sample size requirements to estimate key design parameters from external
pilot randomised controlled trials: a simulation study. Trials. (2014) 15:264.
doi: 10.1186/1745-6215-15-264
98. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux
PJ, et al. Consort 2010 explanation and elaboration: updated guidelines
for reporting parallel group randomised trials. Int J Surg. (2012) 10:28–55.
doi: 10.1016/j.ijsu.2011.10.001
99. Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving
to meet the trustworthiness criteria. Int J Qualitative Methods. (2017) 16:1.
doi: 10.1177/1609406917733847
100. Ardron D, Kendall M. Patient and public involvement in health research:
what is it, and why is it so important? Int J Palliative Nurs. (2010) 16:160–2.
doi: 10.12968/ijpn.2010.16.4.47778
101. Archibald MM. Investigator triangulation: a collaborative strategy with
potential for mixed methods research. J Mixed Methods Res. (2016) 10:228–
50. doi: 10.1177/1558689815570092
Disclaimer: The views expressed in this publication are those of the author(s) and
not necessarily those of the NHS, the National Institute for Health Research or the
Department of Health and Social Care.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Aries, Pomeroy, Sim, Read and Hunter. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Neurology | www.frontiersin.org 24 July 2021 | Volume 12 | Article 675106
